Novo Nordisk A/S
CSE:NOVO B
Novo Nordisk A/S
Cash from Operating Activities
Novo Nordisk A/S
Cash from Operating Activities Peer Comparison
Competitive Cash from Operating Activities Analysis
Latest Figures & CAGR of Competitors
Company | Cash from Operating Activities | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
Novo Nordisk A/S
CSE:NOVO B
|
Cash from Operating Activities
kr108.9B
|
CAGR 3-Years
28%
|
CAGR 5-Years
19%
|
CAGR 10-Years
15%
|
|
H Lundbeck A/S
CSE:HLUN A
|
Cash from Operating Activities
kr4.1B
|
CAGR 3-Years
2%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
|
ALK-Abello A/S
CSE:ALK B
|
Cash from Operating Activities
kr667m
|
CAGR 3-Years
30%
|
CAGR 5-Years
N/A
|
CAGR 10-Years
N/A
|
See Also
What is Novo Nordisk A/S's Cash from Operating Activities?
Cash from Operating Activities
108.9B
DKK
Based on the financial report for Dec 31, 2023, Novo Nordisk A/S's Cash from Operating Activities amounts to 108.9B DKK.
What is Novo Nordisk A/S's Cash from Operating Activities growth rate?
Cash from Operating Activities CAGR 10Y
15%
Over the last year, the Cash from Operating Activities growth was 38%. The average annual Cash from Operating Activities growth rates for Novo Nordisk A/S have been 28% over the past three years , 19% over the past five years , and 15% over the past ten years .